How do I buy shares of Acusphere?

Shares of ACUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ACUS

Acusphere (ACUS) Stock Price, News & Analysis

→ Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad)

Free ACUS Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 16,517 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart

Ad Stansberry Research

Everybody laughed when he recommended Netflix

"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined.

Click here to see how it could become the No. 1 investment of the next decade.

About Acusphere Stock (OTCMKTS:ACUS)

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.

Ad Stansberry Research

Everybody laughed when he recommended Netflix

Click here to see how it could become the No. 1 investment of the next decade.

ACUS Stock News Headlines

July 25, 2023 | investing.com

Guizhou Aviation Technical Development Co Ltd (688239)

June 24, 2023 | morningstar.com

Healthcare Stocks

May 16, 2023 | benzinga.com

Acusphere Stock (OTC:ACUS), Insider Trading Activity

March 27, 2023 | marketwatch.com

Nanotechnology Market Size, Trends and Forecast 2030

February 27, 2023 | marketwatch.com

Nanotechnology Market is Anticipated To Shown Growth by 2027

February 19, 2023 | finance.yahoo.com

Acusphere, Inc. (ACUS) Stock Historical Prices & Data - Yahoo Finance

January 21, 2023 | finance.yahoo.com

Acusphere, Inc. (ACUS)

October 13, 2022 | reuters.com

ACUS.PK - Acusphere, Inc. | Stock Price & Latest News | Reuters

October 4, 2022 | uk.finance.yahoo.com

The global contrast enhanced ultrasound market is expected to register a CAGR of 5.25% during the forecast period, 2022-2030

July 13, 2022 | benzinga.com

Acusphere (OTC:ACUS), Earnings Estimates, EPS, and Revenue

July 6, 2022 | marketwatch.com

Nanotechnology Market Share 2022 Global Trend, Segmentation, Business Growth, Top Key Players Analysis Industry, Opportunities and Forecast to 2027

March 26, 2022 | wsj.com

Amarin Corp. PLC ADR

February 23, 2022 | apnews.com

hC Bioscience Announces $24 Million Series A Financing to Develop Innovative Pipeline of Protein-Editing Therapies

January 15, 2022 | msn.com

10 Best Vibrating Massage Balls January 2022

September 29, 2021 | prnewswire.com

NeuroSense Therapeutics announces the appointment of Mark Leuchtenberger as Chairman of the Board

August 11, 2021 | barrons.com

Acusphere Inc.

See More Headlines

Company Calendar

Today: 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:ACUS
CUSIP: N/A
CIK: N/A
Web: www.acusphere.com
Phone: (617) 648-8800
Fax: 978-863-9993
Employees: 118
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: -1.31

Key Executives

Dr. William I. Ramage D.Phil (Age 70)
Chief Development Officer
Comp: $225.09k

Key Competitors

View All Competitors

ACUS Stock Analysis - Frequently Asked Questions

How do I buy shares of Acusphere?: Shares of ACUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ACUS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings